The application of immune checkpoint inhibitors and FGFR protein tyrosine kinase inhibitors
have made a tremendous breakthrough in bladder cancer therapy. However, inadequate …

Homoharringtonine (HHT), an Food and Drug Administration (FDA)-approved anti-leukemia
drug, exerts anti-tumor activity in several solid tumors, including colorectal cancer (CRC) …

Homoharringtonine (HHT), a natural alkaloid derived from the cephalotaxus, exhibited its
anti-cancer effects in hematological malignancies clinically. However, its pesticide effects …

Tyrosine kinase inhibitors (TKIs) are mostly used in non-small cell lung cancer (NSCLC)
treatment. Unfortunately, treatment with Gefitinib for a period of time will result in drug …

Gallbladder cancer (GBC) is the most common biliary tract tumor with a poor prognosis.
Isorhamnetin is a flavonoid compound extracted from Hippophae rhamnoides L. and has …

Homoharringtonine (HHT) has currently been used successfully in the treatment of acute
and chronic myeloid leukemias and has been shown to induce apoptosis of different types of …

Homoharringtonine (HHT), an approved anti-leukemic alkaloid, has been reported
effectively in many types of tumor cells. However, its effect on melanoma cells has not been …

Background Huachansu (HCS), a class of toxic steroids extracted from toad venom, which
has been shown to be a valuable anticancer drug in many kinds of cancers. However, the …

Although our most recent studies have identified Isorhapontigenin (ISO), a novel derivative
of stilbene that isolated from a Chinese herb Gnetum cleistostachyum, for its inhibition of …

Tanshinone IIA (Tan-IIA) is an extract from the widely used traditional Chinese medicine
(TCM) Danshen (Salvia miltiorrhiza), and has been found to attenuate the proliferation of …